STAT3 and cervical carcinoma: Immunoexpression of p-Stat3 has been recognised as a predictor of poor survival in other malignancies (Horiguchi et al, 2002; Masuda et al, 2002; Rosen et al, 2006; Yang et al, 2007), but, to our knowledge, the correlation between the p-Stat3 expression and prognosis in patients with cervical cancer has not been reported.